The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
81803176 8180317 6 F 1998 20121017 20111013 20121029 EXP US-009507513-1110USA01314 MERCK 0.00 Y 0.00000 20121029 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
81803176 8180317 1 PS FOSAMAX 1 ORAL 10 MG, UNK D 20560 10 MG Tablet
81803176 8180317 2 SS FOSAMAX 1 ORAL 5 MG, UNK D 20560 5 MG Tablet
81803176 8180317 3 SS FOSAMAX 1 ORAL 70 MG, QW D 20560 70 MG Tablet /wk
81803176 8180317 4 SS FOSAMAX 1 ORAL UNK D 20560 Tablet
81803176 8180317 5 C CLARITIN 1 ORAL U 0
81803176 8180317 6 C ALLEGRA 1 ORAL U 0
81803176 8180317 7 C ATIVAN 1 U 0
81803176 8180317 8 C ZESTRIL 1 ORAL U 0 Tablet
81803176 8180317 9 C metoprolol 1 U 0
81803176 8180317 10 C NAPROSYN 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
81803176 8180317 1 Osteopenia
81803176 8180317 2 Osteoporosis
81803176 8180317 4 Osteopenia
81803176 8180317 5 Hypersensitivity
81803176 8180317 6 Hypersensitivity
81803176 8180317 7 Anxiety
81803176 8180317 8 Hypertension
81803176 8180317 9 Hypertension
81803176 8180317 10 Arthritis

Outcome of event

Event ID CASEID OUTC COD
81803176 8180317 OT
81803176 8180317 HO
81803176 8180317 DS

Reactions reported

Event ID CASEID DRUG REC ACT PT
81803176 8180317 Adverse event
81803176 8180317 Alcohol abuse
81803176 8180317 Alcohol poisoning
81803176 8180317 Alcohol use
81803176 8180317 Angina unstable
81803176 8180317 Aortic valve incompetence
81803176 8180317 Arteriosclerosis coronary artery
81803176 8180317 Arthralgia
81803176 8180317 Arthropathy
81803176 8180317 Back pain
81803176 8180317 Breath sounds abnormal
81803176 8180317 Cardiac contusion
81803176 8180317 Cardiac failure congestive
81803176 8180317 Cardiac murmur
81803176 8180317 Carpal tunnel syndrome
81803176 8180317 Cerebral atrophy
81803176 8180317 Cerebrovascular accident
81803176 8180317 Chest discomfort
81803176 8180317 Chest injury
81803176 8180317 Chest pain
81803176 8180317 Cholecystitis
81803176 8180317 Chronic obstructive pulmonary disease
81803176 8180317 Closed fracture manipulation
81803176 8180317 Contusion
81803176 8180317 Coronary artery disease
81803176 8180317 Depression
81803176 8180317 Dizziness
81803176 8180317 Drug ineffective
81803176 8180317 Dyspnoea
81803176 8180317 Dyspnoea exertional
81803176 8180317 Electrocardiogram ST-T change
81803176 8180317 Fall
81803176 8180317 Fatigue
81803176 8180317 Feeling abnormal
81803176 8180317 Femur fracture
81803176 8180317 Flank pain
81803176 8180317 Gait disturbance
81803176 8180317 Gastric ulcer
81803176 8180317 Gastritis
81803176 8180317 Gastrooesophageal reflux disease
81803176 8180317 Haematoma
81803176 8180317 Head injury
81803176 8180317 Headache
81803176 8180317 Hypercholesterolaemia
81803176 8180317 Hypoaesthesia
81803176 8180317 Hypotension
81803176 8180317 Intervertebral disc degeneration
81803176 8180317 Intervertebral disc protrusion
81803176 8180317 Joint lock
81803176 8180317 Low turnover osteopathy
81803176 8180317 Major depression
81803176 8180317 Mitral valve incompetence
81803176 8180317 Mitral valve prolapse
81803176 8180317 Muscular weakness
81803176 8180317 Myocardial infarction
81803176 8180317 Nausea
81803176 8180317 Neck pain
81803176 8180317 Non-cardiac chest pain
81803176 8180317 Osteoarthritis
81803176 8180317 Pain
81803176 8180317 Pain in extremity
81803176 8180317 Pancreatitis acute
81803176 8180317 Physical assault
81803176 8180317 Pneumothorax
81803176 8180317 Post-traumatic stress disorder
81803176 8180317 Presyncope
81803176 8180317 Pyrexia
81803176 8180317 Radius fracture
81803176 8180317 Rheumatoid arthritis
81803176 8180317 Rhinitis allergic
81803176 8180317 Rotator cuff syndrome
81803176 8180317 Sinus bradycardia
81803176 8180317 Skin mass
81803176 8180317 Sleep disorder
81803176 8180317 Syncope
81803176 8180317 Tonsillar disorder
81803176 8180317 Transient ischaemic attack
81803176 8180317 Vision blurred
81803176 8180317 Vitamin K deficiency
81803176 8180317 Wrist fracture

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
81803176 8180317 1 199807 200201 0
81803176 8180317 2 200202 200303 0
81803176 8180317 3 200304 200705 0
81803176 8180317 5 1998 2002 0
81803176 8180317 6 2003 2004 0